rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-7-4
|
pubmed:abstractText |
The association of epidermal growth factor receptor (EGFR) mutations with the response to conventional cytotoxic chemotherapeutic agents in non-small-cell lung cancer patients has not been investigated. We retrospectively analyzed the associations between response to chemotherapy and molecular markers associated with gefitinib responsiveness including EGFR mutations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0368-2811
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
344-50
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:16818479-Antineoplastic Agents,
pubmed-meshheading:16818479-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16818479-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16818479-DNA Mutational Analysis,
pubmed-meshheading:16818479-Deoxycytidine,
pubmed-meshheading:16818479-Genes, erbB-1,
pubmed-meshheading:16818479-Genes, ras,
pubmed-meshheading:16818479-Humans,
pubmed-meshheading:16818479-Immunohistochemistry,
pubmed-meshheading:16818479-Lung Neoplasms,
pubmed-meshheading:16818479-Mutation,
pubmed-meshheading:16818479-Paclitaxel,
pubmed-meshheading:16818479-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:16818479-Quinazolines,
pubmed-meshheading:16818479-Receptor, Epidermal Growth Factor,
pubmed-meshheading:16818479-Retrospective Studies
|
pubmed:year |
2006
|
pubmed:articleTitle |
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer.
|
pubmed:affiliation |
Department of Internal Medicine, Seoul National University College of Medicine, Chongno-Gu, Seoul, 110-744, South Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|